Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores

被引:0
作者
Seyed Reza Najafizadeh
Khatereh Amiri
Maryam Moghaddassi
Shaghayegh Khanmohammadi
Hossein Mirmiranpour
Manouchehr Nakhjavani
机构
[1] Tehran University of Medical Sciences,Rheumatology Research Center, Vali
[2] Tehran University of Medical Sciences,Asr Hospital
[3] Tehran University of Medical Sciences,Department of Clinical Biochemistry, School of Medicine
来源
Clinical Rheumatology | 2021年 / 40卷
关键词
Advanced glycation end products; Advanced oxidation protein products; Ferric reducing ability of plasma; Oxidative stress; Rheumatoid arthritis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4019 / 4026
页数:7
相关论文
共 208 条
[1]  
Silman AJ(2002)Epidemiology and genetics of rheumatoid arthritis Arthritis Res 4 S265-272
[2]  
Pearson JE(2008)Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I Arthritis Rheum 58 15-25
[3]  
Helmick CG(2020)Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014 Ann Rheum Dis 79 440-444
[4]  
Felson DT(2016)Molecular insight into gut microbiota and rheumatoid arthritis Int J Mol Sci 17 431-302
[5]  
Lawrence RC(2012)Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis Am J Manag Care 18 S295-2581
[6]  
Gabriel S(2009)Sex differences in rheumatoid arthritis: more than meets the eye BMC Med 7 12-483
[7]  
Hirsch R(2017)Role of intestinal microbiota and metabolites on gut homeostasis and human diseases BMC Immunol 18 2-106
[8]  
Kwoh CK(2010)2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Arthritis Rheum 62 2569-232
[9]  
Liang MH(2010)2010 ACR-EULAR classification criteria for rheumatoid arthritis Rev Bras Reumatol 50 481-129
[10]  
Kremers HM(2013)Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis J Investig Allergol Clin Immunol 23 101-1196